What is Cliniq Tes AI for Lung Cancer?
iCliniq Tes is your AI-powered lung cancer companion, crafted by expert physicians to help you understand symptoms, treatment options, and coping strategies. Get personalized, expert-driven support to manage your lung cancer journey with confidence.
Problem
Users struggle to understand symptoms, treatment options, and coping strategies for lung cancer, leading to anxiety and uncertainty due to fragmented or unreliable medical information.
Solution
An AI-powered health companion tool that provides personalized guidance on lung cancer management. Users input symptoms and receive tailored insights, treatment explanations, and coping strategies, e.g., clarifying chemotherapy side effects or suggesting symptom-specific exercises.
Customers
Lung cancer patients and their caregivers (ages 40+, often digitally engaged but lacking medical expertise) seeking actionable, physician-backed advice.
Unique Features
Content curated by practicing oncologists, real-time symptom-to-treatment mapping, and emotional coping modules integrated with clinical guidance.
Market Size
The global AI healthcare market was valued at $20.9 billion in 2024 (Statista), with oncology-focused AI tools growing at 28% CAGR due to rising cancer prevalence.
